Searchable abstracts of presentations at key conferences in endocrinology

ea0049oc9.1 | Thyroid Disease 2 | ECE2017

Thyroid function and metabolic syndrome: results from the population-based LifeLines Cohort study

Wolffenbuttel Bruce , Wouters Hanneke , Slagter Sandra , van Waateringe Robert , van Vliet-Ostaptchouk Jana , Links Thera , van der Klauw Melanie

Background: The metabolic syndrome (MetS) is a combination of unfavourable health factors including abdominal obesity, dyslipidaemia, hypertension and impaired fasting glucose. Several small-scale studies have reported a relationship between thyroid function and some MetS components or suggested that serum FT3 levels within the normal range were independently associated with insulin resistance. We assessed how thyroid function relates to the prevalence of MetS in a large popul...

ea0049ep672 | Obesity | ECE2017

Unfavourable blood pressure and lipid levels in obese individuals from the general population

Wolffenbuttel Bruce , Slagter Sandra , van Waateringe Robert , van Vliet-Ostaptchouk Jana , van Beek Andre , van der Klauw Melanie

Background: Early diagnosis and treatment of high blood pressure (BP) and high cholesterol is important to reduce cardiovascular mortality risk.Methods: We assessed actual BP and LDL-cholesterol (LDL-C) levels in 88,029 participants (36,122 men), aged 18-80 yrs, without diabetes, from the Dutch Lifelines Cohort study. Participants were categorized according to degree of obesity (normal weight, overweight, obese) and age decade group. BP measurement was r...

ea0041gp71 | Diabetes | ECE2016

A critical evaluation of the metabolic syndrome definition: why we should be more cautious

Slagter Sandra , van Waateringe Robert , van Beek Andre , van der Klauw Melanie , van Vliet-Ostaptchouk Jana , Wolffenbuttel Bruce

Aim: We assessed in both men and women within different BMI- and age classes the prevalence of MetS and its individual components, since these specific estimates obtained simultaneously in a large western European population are lacking. Secondly, we measured as well how age-specific blood pressure (BP) cut-offs affect the prevalence of elevated BP and MetS.Methods: Data of 74 531 western European participants, aged 18–79 years, were obtained from t...

ea0056gp193 | Pituitary / Growth Hormone ' IGF Axis | ECE2018

Hypophysitis due to immune checkpoint blockade: rising numbers.

van den Berg Gerrit , van den Brom Rob , van der Klauw Melanie , Hiltermann Jeroen , Hospers Geke , Links Thera

Hypophysitis is one of the immune-related adverse events of immune checkpoint blockade. This complication is potentially dangerous, mainly because of the insidious development of a life-threatening hypocortisolism. Unnecessary morbidity or mortality in an oncological responder may be the result. The number of patients treated with immune checkpoint inhibitors increases rapidly, due to the expansion of indications and trials. Moreover, the introduction of combination schedules ...

ea0090oc11.6 | Oral Communications 11: Late Breaking | ECE2023

Assessment of clinical and histopathological predictors for remission after transsphenoidal surgery for acromegaly

Postma Mark , Westerlaan Henriette , Willems Annet , van den Beukel Anke , Kuijlen Jos , Vergeer Rob , van der Klauw Melanie , Dunnen Wilfred den , van Beek Andre

Background: Transsphenoidal surgery (TSS) is the primary treatment of choice in acromegaly. Previous research succeeded to some extent in predicting remission after TSS. However, it was based mainly on clinical and radiological data, lacking histopathological evaluation.Objective: To produce a clinicopathological prediction model for remission after TSS for acromegaly, enabling clinicians to better inform patients on expected treatment outcome.<p cla...

ea0041ep779 | Obesity | ECE2016

Skin autofluorescence is associated with the metabolic syndrome and its individual components

van Waateringe Robert , Slagter Sandra , van Vliet-Ostaptchouck Jana , Graaff Reindert , van der Klauw Melanie , Paterson Andrew , Lutgers Helen , Wolffenbuttel Bruce

Background: Skin autofluorescence (SAF) has been demonstrated to be associated with long-term cardiovascular complications in subjects with either diabetes or renal failure. Since the metabolic syndrome (MetS) is a risk factor for cardiovascular disease, the aim of the study was to assess the association between SAF and MetS as well as its individuals components.Materials and methods: For this cross-sectional analysis, we included subjects 18–80 yea...

ea0037ep927 | Thyroid (non-cancer) | ECE2015

Health-related quality of life is reduced in treated primary hypothyroidism and with lower fT3/fT4-ratio

van Loon Hannah C M , Wouters Hanneke J C M , Kobold Anneke Muller , Slagter Sandra N , Links Thera P , van der Klauw Melanie M , Wolffenbuttel Bruce H R

Introduction: Despite adequate treatment with LT4 monotherapy, many patients with primary hypothyroidism still report complaints, as this treatment can not exactly imitate the endogenous homeostasis. We examined whether the different domains of HR-QOL were affected by the existence of a thyroid disorder and use of LT4 substitution, and whether a lower ratio of free triiodothyronine (fT3)–free thyroxine (fT4)</sup...

ea0056gp247 | Thyroid non cancer | ECE2018

Serum FT4 levels predict incidence of type 2 diabetes and cardiovascular disease in the general population

Wolffenbuttel Bruce HR , van Vliet-Ostaptchouk Jana V , van Waateringe Robert P , Wouters Hanneke JCM. , Slagter Sandra N , Graaff Reindert , van der Klauw Melanie M

Background: Skin autofluorescence (SAF), measured with the AGE-reader, predicts cardiovascular disease (CVD) and type 2 diabetes (T2D). Thyroid hormone levels (TH) may affect this association. In the present study, we examined whether TH predict 4-years risk of T2D, CVD and mortality in the general population independently of SAF.Methods: We included 28245 participants (age 44±12 years, BMI 25.9±4.3 kg/m2) of the Dutch Lifelines Coho...

ea0041gp152 | Pituitary - Clinical | ECE2016

Effects of hydrocortisone substitution on blood pressure – results from an RCT

Buning Jorien Werumeus , van Faassen Martijn , Brummelman Pauline , Dullaart Robin P F , van den Berg Gerrit , van der Klauw Melanie M , Kerstens Michiel N , Kobold Anneke C Muller , Kema Ido P , Wolffenbuttel Bruce H R , van Beek Andre P

Background: Patients with secondary adrenal insufficiency show increased risk of cardiovascular disease. Higher doses of glucocorticoid replacement are related to an unfavourable metabolic profile. In the absence of randomized controlled trials assessing the effect of hydrocortisone dose on haemodynamics and blood pressure regulation, we determined effects of a higher vs a lower glucocorticoid replacement dose on blood pressure, the renin-angiotensin-aldosterone system (RAAS) ...

ea0037gp.20.06 | Pituitary – Hypopituitarism | ECE2015

Somatic complaints, pain and health related quality of life in patients treated for secondary adrenal insufficiency – results from a randomised controlled trial

Buning Jorien Werumeus , Brummelman Pauline , Koerts Janneke , Dullaart Robin P F , van den Berg Gerrit , van der Klauw Melanie M , Tucha Oliver , Wolffenbuttel Bruce H R , van Beek Andre P

Introduction: There is growing evidence that quality of life (QoL) in patients with adrenal insufficiency (AI) is impaired. Undertreatment with glucocorticoids is associated with symptoms such as fatigue and gastrointestinal complaints whereas overtreatment is associated with impaired QoL. However, evidence for this is derived from observational studies which are prone to bias. Therefore, the aim of the present study was to compare two different physiological doses of hydrocor...